Brief: Magle Extends Acceptance Period For Offer To Shareholders Of Amniotics

Magle Chemoswed Holding AB

07/05/2024 16:03

May 7 (Reuters) - Magle Chemoswed Holding AB  MAGLE.ST :
    * MAGLE GROUP REPORTS OUTCOME AND EXTENDS ACCEPTANCE PERIOD
FOR
PUBLIC TENDER OFFER TO SHAREHOLDERS OF AMNIOTICS
    * ON 3 MAY 2024, OFFER HAD BEEN ACCEPTED BY SHAREHOLDERS OF
AMNIOTICS REPRESENTING 1,612,363,380 SHARES, 59.0% OF
OUTSTANDING SHARES, VOTES
    * HAS DECIDED TO EXTEND ACCEPTANCE PERIOD FOR OFFER UP TO
AND
INCLUDING 15:00 ON 17 MAY 2024
    * MAGLE GROUP REGRETS TO ANNOUNCE A DISAPPOINTING OUTCOME OF
SHAREHOLDER UPTAKE IN ITS OFFER FOR AMNIOTICS
    * OFFER, INITIATED AS A RESCUE EFFORT, AIMED TO ACQUIRE AT
LEAST
90 PER CENT OF OUTSTANDING SHARES IN AMNIOTICS AND SUBSEQUENTLY
PROMOTE A DELISTING OF AMNIOTICS FROM STOCK EXCHANGE

Source text for Eikon:  ID:nMFNbnP6Vj 
Further company coverage:  MAGLE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))